Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

9d ago

EDIT

PremiumPress Releases

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

17d ago

EDIT

PremiumPress Releases

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

27d ago

EDIT

PremiumPress Releases

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

3M ago

EDIT

PremiumPress Releases

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

3M ago

EDIT

PremiumPre-Earnings

Is EDIT a Buy, Before Earnings?

3M ago

EDIT

More EDIT News >

EDIT News on the Web

2024-05-16

3 Pharma Stocks Primed for May Investment Opportunities

StockNews

Neutral

2024-05-14

Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc

Yahoo Finance

Neutral

2024-05-14

Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc (EDIT)

GuruFocus News

Neutral

2024-05-14

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

Yahoo Finance

Neutral

2024-05-12

Editas Medicine, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Yahoo Finance

Neutral

2024-05-10

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

Yahoo Finance

Neutral

2024-05-09

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?

The Motley Fool

Bullish

2024-05-09

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?

Motley Fool

Neutral

News Score - Last 7 Days

Neutral

EDIT

Sector Average

Media Buzz

This Week4 articles

Weekly Average6.25 articles

News Sentiment

This Week50%

Sector Average62%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EDIT’s Media Buzz Sentiment?

4 articles about EDIT were published this week. In an average week, 6.25 articles are published.

What is EDIT’s weekly average amount of articles?

In an average week, 6.25 articles about EDIT are published.

What is EDIT’s News Sentiment?

50% of articles about EDIT were positive this week, compared to its sector average of 62%.

Healthcare Stocks that are Trending in the News

PYXSPyxis Oncology

EPIXESSA Pharma

DOCSDoximity

STXSStereotaxis

CABACabaletta Bio

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing